Clinical Trial for New Indication of DJO Bone Growth Stimulators

DJO Global announced a clinical trial for a new indication of the CMF OL1000™ Bone Growth Stimulator.

The company's Encore Medical subsidiary applied for an Investigational Device Exemption (IDE) study with FDA for an indication of the Combined Magnetic Field (CMF) technology in the fresh fracture market. The prospective, randomized,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us